Royal Bank Of Canada Maia Biotechnology, Inc. Transaction History

Royal Bank Of Canada

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.96 - $5.1 $113 - $295	58 Added 207.14%	86 $0
Q1 2024 Nov 05, 2024	SELL	$1.1 - $2.55 $63 - $147	-58 Reduced 67.44%	28 $0
Q1 2024 May 15, 2024	SELL	$1.1 - $2.55 $132 - $306	-120 Reduced 81.08%	28 $0
Q4 2023 Feb 14, 2024	BUY	$0.83 - $2.54 $100 - $307	121 Added 448.15%	148 $0
Q2 2023 Aug 14, 2023	BUY	$2.11 - $3.84 $56 - $103	27 New	27 $0
Q3 2022 Nov 14, 2022	BUY	$3.25 - $7.8 $71 - $171	22 New	22 $0

1.47M

Ticker MAIA
Exchange
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,935,900
Market Cap $22.6M
Description
MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.